Antibiotic resistance, a global health concern, has been largely attributed to the irrational use of antibiotics. Therefore, promoting rational use of antibiotics is crucial in modern medicine.
Antibiotic stewardship is a coordinated strategy to improve and measure the appropriate use of antibiotics. It promotes the selection of the optimal antibiotic regimen, dose, duration of therapy, and route of administration. Stewardship efforts can significantly reduce overuse and misuse of antibiotics, thereby reducing resistance.
Firstly, antibiotics should only be prescribed when there is evidence of a bacterial infection. Secondly, the choice of antibiotic should be based on the susceptibility pattern of the causative organism. Thirdly, the dose and duration of antibiotic therapy should be appropriate for the type and site of infection. Lastly, the patient's clinical response should be monitored to assess the effectiveness of the treatment.
Diagnostic tests play a pivotal role in the rational use of antibiotics. These tests can help identify the causative organism and its antibiotic susceptibility pattern, enabling physicians to select the appropriate antibiotic. Rapid diagnostic tests can also limit the unnecessary use of broad-spectrum antibiotics while awaiting culture results.
Education of patients about the appropriate use of antibiotics is essential. Patients should be informed about the risks associated with unnecessary antibiotic use, including the development of antibiotic resistance. They should also be educated about the importance of adhering to the prescribed antibiotic regimen.
The rational use of antibiotics is a shared responsibility of healthcare providers and patients. Through antibiotic stewardship, diagnostic tests, and patient education, we can promote patient health and combat antibiotic resistance. It is essential that we continue to strive for the judicious use of antibiotics in modern medicine.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation